Skip to main content
Educational Guide · GLP-1 & Weight Management

Compounded vs. Brand-Name GLP-1

By the UnitedWellness editorial team · Updated March 2026 · 7 min read

Medical note: This guide is for educational purposes only. GLP-1 medications require a prescription from a licensed healthcare provider. Regulatory status around compounded medications can change as shortage declarations are updated. Consult your provider with specific questions about your prescription.

Most GLP-1 telehealth programs use compounded semaglutide or compounded tirzepatide rather than the brand-name products you’ve seen advertised. The cost difference is significant - compounded versions run a fraction of what brand-name products cost out of pocket. But the difference isn’t just price. Here’s what you actually need to know before choosing a program.

What compounding means

Compounding is the practice of creating a medication from its active ingredients at a licensed compounding pharmacy. Compounded medications are made to order, usually for patients with specific needs - a different dose than the manufacturer offers, a different delivery form, or when a shortage makes the brand product unavailable.

Compounded semaglutide contains the same active ingredient as Ozempic and Wegovy. It is not a generic - generics are FDA-approved copies of approved products. Compounded medications exist in a different regulatory category: they are made under state pharmacy law rather than FDA drug approval, which means they haven’t gone through the same manufacturing oversight process as brand-name products.

Under federal law, compounding pharmacies can legally produce a compounded version of an FDA-approved drug when that drug is on the FDA’s drug shortage list. The FDA has declared shortages of semaglutide products, which created the legal basis for compounders to produce it.

This legal basis is not permanent. If the FDA removes semaglutide from the shortage list - which it has done for certain presentations of the drug - the legal basis for compounding that product narrows or disappears. This is an area to watch. Reputable programs track these regulatory changes and adjust accordingly.

What “quality varies” actually means

You will see this phrase in almost every discussion of compounded GLP-1s. It means something specific. Brand-name medications are manufactured under FDA’s Current Good Manufacturing Practice (cGMP) regulations - rigorous standards for consistency, purity, potency, and sterility that every batch must meet before it ships. Compounded medications are not subject to cGMP. They are regulated at the state level, and the standards vary.

This doesn’t mean compounded medications are inherently unsafe. Most compounding pharmacies produce medications that meet appropriate quality standards. But the verification layer is different - and lower - than what brand-name drugs go through. The practical implication: the pharmacy your program uses matters, and it’s worth asking about.

How to evaluate the pharmacy your program uses

Two markers that indicate a higher-quality compounding operation:

PCAB accreditation (Pharmacy Compounding Accreditation Board) - a voluntary accreditation that requires meeting quality standards beyond the state licensing minimum. Not every good pharmacy has it, but it’s a meaningful signal when present.

503B outsourcing facility registration - 503B facilities operate under stricter federal oversight than standard compounding pharmacies. They can produce larger batches and are subject to FDA inspection under cGMP-like standards. Medications from 503B facilities are generally considered higher quality and more consistent than from standard 503A pharmacies.

When evaluating a GLP-1 program, ask: which pharmacy fills my prescription, and is it a PCAB-accredited or 503B-registered facility? A program that can’t answer this question clearly is one to scrutinize.

The cost difference

Brand-name semaglutide without insurance runs $900 to $1,400 per month at full retail pricing. Compounded semaglutide through telehealth programs typically runs $150 to $300 per month depending on dose and program. That’s a substantial gap. For the majority of patients without insurance coverage for brand-name GLP-1s, compounded is the financially realistic option.

With insurance that covers brand-name GLP-1s for weight management, the calculation changes. Some patients pay $0 to $25 per month for Wegovy through insurance. If your plan covers it, brand-name becomes the obvious choice. See our GLP-1 cost guide for a full breakdown of how insurance affects cost across programs.

Which one is right for you

Brand-name is the right answer if you have insurance that covers it for weight management, or if you have specific clinical reasons your provider recommends the brand product. The manufacturing quality argument clearly favors brand-name products.

Compounded is a reasonable choice if you don’t have insurance coverage for brand-name GLP-1s, your program uses a reputable 503B or PCAB-accredited pharmacy, and the cost difference is meaningful to your decision. Most people using telehealth GLP-1 programs are in this situation.

The worst answer is compounded semaglutide from a program that can’t tell you which pharmacy fills your prescription or what quality verification they use. That’s not about compounding being inherently risky - it’s about not knowing what you’re getting.

See how the major programs approach this in our full GLP-1 programs comparison.

Frequently asked questions

Both contain semaglutide as the active ingredient, but they are not the same product. Ozempic is FDA-approved and manufactured under strict federal quality standards. Compounded semaglutide is made by a licensed compounding pharmacy and is not subject to the same FDA manufacturing oversight. Quality depends on the specific pharmacy.
The active ingredient is the same as in brand-name products. Whether a specific compounded product is safe depends on the pharmacy producing it - its quality controls, sterility practices, and consistency. Asking which pharmacy your program uses and whether it holds PCAB accreditation or 503B registration is the most meaningful thing you can do to evaluate quality. UnitedWellness does not assess the safety of individual compounding pharmacies. Discuss your specific situation with a licensed provider.
Yes. If your insurance coverage changes, if your program begins working with brand-name manufacturers, or if you decide to pursue a prior authorization through your insurer, switching is possible. Discuss with your prescribing provider. The dose conversion is straightforward since both use the same active ingredient, but your provider should guide the transition.
A 503B outsourcing facility is a compounding pharmacy that has registered with the FDA and operates under stricter federal oversight than standard compounding pharmacies. They are subject to FDA inspections and quality standards that more closely resemble those applied to drug manufacturers. Medications from 503B facilities are generally considered more consistent than those from standard 503A compounding pharmacies.

UnitedWellness.com participates in affiliate programs and may earn a commission if you click a link and sign up for a service. This does not affect our editorial independence or provider rankings. Pricing shown is approximate and may vary by location, eligibility, and medication type. Content on this site is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any treatment or wellness program. See our disclosure policy.